Back to Search Start Over

Performance of the birmingham vasculitis activity score and disease extent index in childhood vasculitides

Authors :
Demirkaya, E.
Ozen, S.
Pistorio, A.
Galasso, R.
Ravelli, A.
Hasija, R.
Baskin, E.
Dressler, F.
Fischbach, M.
Consuegra, J. G.
Iagaru, N.
Pasic, S.
Scarpato, S.
Rossum, M. A. J.
Apaz, M. T.
Barash, J.
Calcagno, G.
Gonzalez, B.
Hoppenreijs, E.
Ioseliani, M.
Mazur-Zielinska, H.
Vougiouka, O.
Wulffraat, N.
Luqmani, R.
Martini, A.
NICOLINO RUPERTO
Dolezalova, P.
Amsterdam institute for Infection and Immunity
Paediatric Infectious Diseases / Rheumatology / Immunology
Source :
Scopus-Elsevier, Clinical and experimental rheumatology, 30(1 70), S162-S168. Clinical and Experimental Rheumatology S.A.S.

Abstract

Objectives. To evaluate the performance of the Birmingham Vasculitis Activity Score (BVAS) v3 and the Disease Extent Index (DEI) for the assessment of disease activity in 4 primary childhood (c-) systemic vasculitides. Methods. Patients fulfilling the EU-LAR/PRINTO/PRES (Ankara) c-vasculitis classification criteria for Henoch-Schonlein purpura (HSP), childhood (c) polyarteritis nodosa (c-PAN), c-Wegener's granulomatosis (c-WG) and c-Takayasu arteritis (c-TA) with disease duration at the time of diagnosis 1.5) for both tools. The performance characteristics of the BVAS and DEI with the unweighted methods were comparable. Conclusion. This study demonstrates that both the BVAS and DEI are valid tools for the assessment of the level of disease activity in a large cohort of childhood acute and chronic vasculitides

Details

ISSN :
0392856X
Database :
OpenAIRE
Journal :
Scopus-Elsevier, Clinical and experimental rheumatology, 30(1 70), S162-S168. Clinical and Experimental Rheumatology S.A.S.
Accession number :
edsair.dedup.wf.001..1180b69db65001a27732701bb80d34c5